MedTrace Logo

ALTo endogrAft Italian Registry

NCT05234892 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-07-20

No results posted yet for this study

Summary

The aim of present study is to evaluate intraoperative, peri-operative, and post-operative results in patients treated by the ALTO stent graft (Endologix Inc. Irvine, Calif) for elective Abdominal Aortic Aneurysm repair in a multicentric consecutive experience.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

ALTO endograft implantation

Implantantion of aorto-bisiliac ALTO endograft to exclude Abdominal Aortic Aneurysms

Sponsors & Collaborators

  • University of Roma La Sapienza

    collaborator OTHER

  • University of Siena

    collaborator OTHER

  • Gianmarco de Donato

    lead OTHER

Principal Investigators

  • Gianmarco de Donato, MD, PhD · University of Siena

  • Maurizio Taurino, MD, PhD · University La Sapienza of Rome

  • Francesco Talarico, MD, PhD · Ospedale Civico di Palermo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2027-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05234892 on ClinicalTrials.gov